The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis

Research output: Contribution to journalReview article

Standard

Harvard

APA

Vancouver

Author

Bibtex

@article{edf754e95c82407b85fd301749c595d8,
title = "The eye and inflammatory rheumatic diseases:: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis",
abstract = "Rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis are associated with potentially sight-threatening inflammatory eye disease. Although the ocular manifestations associated with ankylosing spondylitis and psoriatic arthritis are similar, such as anterior uveitis, this differs from rheumatoid arthritis where dry eye, peripheral ulcerative keratitis and scleritis are the major ocular complications. Apart from causing sight loss, these conditions are painful, debilitating, often recurrent or chronic and may require long-term therapy. Treatments such as ocular lubricant, topical corticosteroid, systemic corticosteroid and systemic immunosuppression are often similar for the underlying systemic disease. Yet for the treatment of the ocular complications, the evidence base is weak. Close collaboration with a rheumatologist is often essential, particularly in the management of these patients.",
keywords = "Anterior uveitis, Dry eye, Peripheral ulcerative keratitis, Scleritis",
author = "Murray, {Philip Ian} and Saaeha Rauz",
year = "2016",
month = oct,
day = "1",
doi = "10.1016/j.berh.2016.10.007",
language = "English",
volume = "30",
pages = "802--825",
journal = "Best Practice & Research: Clinical Rheumatology",
issn = "1521-6942",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - The eye and inflammatory rheumatic diseases:

T2 - The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis

AU - Murray, Philip Ian

AU - Rauz, Saaeha

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis are associated with potentially sight-threatening inflammatory eye disease. Although the ocular manifestations associated with ankylosing spondylitis and psoriatic arthritis are similar, such as anterior uveitis, this differs from rheumatoid arthritis where dry eye, peripheral ulcerative keratitis and scleritis are the major ocular complications. Apart from causing sight loss, these conditions are painful, debilitating, often recurrent or chronic and may require long-term therapy. Treatments such as ocular lubricant, topical corticosteroid, systemic corticosteroid and systemic immunosuppression are often similar for the underlying systemic disease. Yet for the treatment of the ocular complications, the evidence base is weak. Close collaboration with a rheumatologist is often essential, particularly in the management of these patients.

AB - Rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis are associated with potentially sight-threatening inflammatory eye disease. Although the ocular manifestations associated with ankylosing spondylitis and psoriatic arthritis are similar, such as anterior uveitis, this differs from rheumatoid arthritis where dry eye, peripheral ulcerative keratitis and scleritis are the major ocular complications. Apart from causing sight loss, these conditions are painful, debilitating, often recurrent or chronic and may require long-term therapy. Treatments such as ocular lubricant, topical corticosteroid, systemic corticosteroid and systemic immunosuppression are often similar for the underlying systemic disease. Yet for the treatment of the ocular complications, the evidence base is weak. Close collaboration with a rheumatologist is often essential, particularly in the management of these patients.

KW - Anterior uveitis

KW - Dry eye

KW - Peripheral ulcerative keratitis

KW - Scleritis

UR - http://www.scopus.com/inward/record.url?scp=85003530636&partnerID=8YFLogxK

U2 - 10.1016/j.berh.2016.10.007

DO - 10.1016/j.berh.2016.10.007

M3 - Review article

C2 - 27964790

AN - SCOPUS:85003530636

VL - 30

SP - 802

EP - 825

JO - Best Practice & Research: Clinical Rheumatology

JF - Best Practice & Research: Clinical Rheumatology

SN - 1521-6942

IS - 5

ER -